The content on this site is intended for healthcare professionals only
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 8-14, 2023.
He begins by highlighting the AACR Cancer Progress Reports which are centred around recent developments of cancer research and identifying priority efforts for future efforts.
Dr Morgan details a Lancet paper on the promising combination of FOLFOX plus regorafenib and nivolumab for advanced EG cancer.
He also highlights noteworthy studies in triple-negative breast cancer, prostate cancer, non-small cell lung cancer and head and neck squamous cell carcinoma.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Prostate cancer
Breast cancer
Introducing oncology to undergraduate medical and allied health sciences students
OncoAlert Round Up for September 15-21, 2023
Treating cancer in the heart of the Ukraine conflict
ASCO's efforts to improve global cancer care through the years
US NCI's global health initiatives at ASCO 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
